Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
$4 Billion Investment and 4,000 Jobs from Corning, Merck, and Pfizer Initiative
On Thursday, the CEOs of Corning, Merck, and Pfizer pharmaceutical companies were welcomed to the White House by President Donald J.
EU approves LEO Pharma’s psoriasis biologic
A new treatment option has been approved in the European Union for patients with psoriasis, paving the way for access to a novel approach for those with moderate-to-severe forms of the disease who are...
Paratek Announces Phase 3 Study of Oral-Only Dosing of Omadacycline Met All Primary and Secondary FDA and EMA Efficacy Endpoints in Acute Bacterial Skin Infections
BOSTON, July 17, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc.
Vertex stock rockets to record, boosting market cap by $8 billion
Vertex Pharmaceuticals Inc.
Shire pens bispecific hemophilia R&D deal with Novimmune
As the hemophilia market builds and tensions fray, Shire has signed a new licensing deal targeting bispecific antibodies.
FDA collaborates to promote safety, quality in clinical trials done in India
After more than 16 hours of travel, we touch down in Mumbai late in the evening and are greeted by a wave of heat and humidity as we exit the airport terminal.
FDA approves Vosevi for Hepatitis C
The U.
China adds blockbuster drugs to insurance list after price cuts
SHANGHAI (Reuters) - China will add three dozen new drugs to a list of medicines covered by basic insurance schemes after global pharmaceutical firms agreed to slash prices of blockbuster trea...
FDA approves new treatment to reduce the risk of breast cancer returning
The U.
27 Phase III and 8 Phase II Alzheimer's drugs on track to launch in next five years
Twenty-seven Alzheimer's drugs in Phase III clinical trials and eight drugs in Phase II clinical trials may launch in the next five years, according to a revised Alzheimer's pipeline analysis ...
M&As this week: Sanofi, GE Healthcare, Medicure
Sanofi has announced plans to acquire US-based vaccines biotechnology company, Protein Sciences Corporation.
Deals this week: North China Pharmaceutical, Arena Pharmaceuticals, Enterome Bioscience
Chinese pharmaceutical company North China Pharmaceutical has announced the completion of a public offering of ten million short-term bonds to raise CNY1bn ($146.
524
525
526
527
528
529
530
531
532
